About us
The InnoSIGN team is committed to transform cancer care by enabling personalized targeted therapy options through OncoSIGNal pathway activity profiling. Our team has a wealth of experience in bringing innovative diagnostic solutions to the market.
revolutionizing precision medicine
Board of Directors
Allan May
Chairman - Life Science Angels
Evan Castiglia
Thuja Capital
Mark Oldroyd
Independent Board Member
Eric Lindquist
CEO InnoSIGN
Paul Vernooij
Observer BOM
Benno Tieke
Observer Philips
Paul van de Wiel
Observer InnoSIGNMeet the team
Eric Lindquist
Chief Executive Officer
Paul van de Wiel
Chief Operating Officer
Sigi Neerken
Chief Business Officer
Eveline den Biezen
Chief Scientific Officer
Anke Pierik
Chief Technology Officer
Robert Babkowski MD
CLIA Lab Medical Director
Anne van Brussel
Application Scientist
Sandra Gunselman
Director CLIA Lab Operations
Laurent Holtzer
Solutions Architect
Diederick Keizer
Clinical Operation Manager
Dianne van Strijp
Product Application Specialist
Gwen Sülter
MARCOM Specialist
Saskia Vermeer
Service Lab Manager
Yvonne Wesseling-Rozendaal
Clinical Data Scientist
Janneke Wrobel
Quality Engineer